Interpret
Reading File
Finding Sources
Finding Sources
Finding Sources
Now I have enough to provide a thorough interpretation. Here is the full clinical analysis:
Lab Report Interpretation - Ram Chandra Bhoi, 52Y/M
Thyrocare Aarogyam Camp Profile 1 | Collected: 11 Jun 2026
🔴 ABNORMAL FINDINGS SUMMARY
1. DIABETES - POORLY CONTROLLED
| Test | Value | Reference | Status |
|---|---|---|---|
| HbA1c | 8% | < 5.7% (Normal) | 🔴 HIGH |
| Average Blood Glucose (ABG) | 183 mg/dL | 90-120 mg/dL | 🔴 HIGH |
Interpretation:
- HbA1c of 8% reflects the average blood sugar over the past 2-3 months. This falls in the "Fair Control" zone (6.5-7% = Good, >7% = Poor) per ADA guidelines.
- The ABG of 183 mg/dL confirms persistent hyperglycemia.
- This patient is a known or newly diagnosed diabetic with inadequate glycemic control. The ADA target for most diabetics is HbA1c < 7%.
- Action needed: Medication review/initiation, dietary modification, and regular monitoring.
2. LIPID PANEL - MULTIPLE ABNORMALITIES (Cardiovascular Risk)
| Test | Value | Reference | Status |
|---|---|---|---|
| LDL Cholesterol (Direct) | 120 mg/dL | < 100 mg/dL | 🔴 HIGH |
| HDL Cholesterol (Direct) | 36 mg/dL | 40-60 mg/dL | 🔴 LOW |
| Triglycerides | 177 mg/dL | < 150 mg/dL | 🔴 HIGH |
| HDL/LDL Ratio | 0.3 | > 0.40 | 🔴 LOW |
| Trig/HDL Ratio | 4.87 | < 3.12 | 🔴 HIGH |
Interpretation:
- Low HDL ("good cholesterol") at 36 mg/dL is a major independent cardiovascular risk factor.
- Elevated LDL ("bad cholesterol") at 120 mg/dL - for a diabetic patient, the target is typically < 70-100 mg/dL, making this especially concerning.
- Elevated triglycerides at 177 mg/dL, consistent with metabolic syndrome (often seen with diabetes, central obesity, insulin resistance).
- The Trig/HDL ratio of 4.87 is significantly elevated. A ratio > 3.5 is a strong surrogate marker for insulin resistance and small dense LDL particles - the most atherogenic lipoprotein pattern.
- Combined with diabetes, this lipid profile substantially elevates the risk of heart attack and stroke.
- Action needed: Statin therapy (e.g., atorvastatin), lifestyle modification - reduce refined carbs, exercise, omega-3s for triglycerides.
3. LIVER FUNCTION TESTS - MILDLY ABNORMAL
| Test | Value | Reference | Status |
|---|---|---|---|
| SGPT/ALT | 73.2 U/L | < 45 U/L | 🔴 HIGH (~1.6x upper limit) |
| SGOT/AST | 56.7 U/L | < 35 U/L | 🔴 HIGH (~1.6x upper limit) |
| Alkaline Phosphatase (ALP) | 142.5 U/L | 45-129 U/L | 🟡 BORDERLINE HIGH |
| Serum Globulin | 3.48 g/dL | 2.5-3.4 g/dL | 🟡 MILDLY HIGH |
| GGT | 41.6 U/L | < 55 | ✅ Normal |
| Bilirubin (Total) | 0.53 mg/dL | 0.3-1.2 | ✅ Normal |
| Albumin | 4.36 g/dL | 3.2-4.8 | ✅ Normal |
| Total Protein | 7.84 g/dL | 5.7-8.2 | ✅ Normal |
| A/G Ratio | 1.25 | 0.9-2 | ✅ Normal |
Interpretation:
- SGPT > SGOT with both at ~1.5-2x upper limit of normal is the classic pattern of Non-Alcoholic Fatty Liver Disease (NAFLD), which is extremely common in patients with diabetes and metabolic syndrome (as seen here).
- The ALP elevation is mild and may reflect hepatic infiltration (fatty liver) or early biliary involvement - worth monitoring.
- Bilirubin is normal, albumin is normal, and A/G ratio is normal - these are reassuring signs that liver synthetic function is preserved and there is no significant liver failure or cirrhosis.
- GGT is normal, which makes significant alcohol-related liver disease less likely.
- Action needed: Ultrasound of the abdomen to assess for fatty liver, repeat LFTs in 3 months, alcohol abstinence, weight loss.
4. COMPLETE BLOOD COUNT - ABNORMAL INDICES
| Test | Value | Reference | Status |
|---|---|---|---|
| WBC (Total Leucocytes) | 10.19 x10³/µL | 4.0-10.0 | 🟡 MILDLY HIGH |
| MCHC | 30.5 g/dL | 31.5-34.5 | 🔴 LOW |
| MPV (Mean Platelet Volume) | 13.1 fL | 6.5-12 | 🟡 HIGH |
| PDW (Platelet Distribution Width) | 18 fL | 9.6-15.2 | 🟡 HIGH |
| PLCR (Platelet to Large Cell Ratio) | 48.9% | 19.7-42.4 | 🟡 HIGH |
| RDW-CV | 14.5% | 11.6-14 | 🟡 MILDLY HIGH |
| RDW-SD | 52.5 fL | 39-46 | 🟡 HIGH |
Interpretation:
- Low MCHC (30.5) indicates hypochromia - red blood cells have less hemoglobin than normal. This is characteristic of iron deficiency anemia or thalassemia trait.
- Elevated RDW (both CV and SD) indicates anisocytosis - red blood cells varying in size, which is a hallmark of iron deficiency anemia or mixed nutritional deficiency (B12/folate + iron).
- Elevated MPV (13.1), PDW (18), and PLCR (48.9) suggest platelet activation - larger, more active platelets. This is seen in cardiovascular disease states, diabetes, and metabolic syndrome. Elevated MPV is itself an independent cardiovascular risk marker.
- Mildly elevated WBC (10.19) - just above the upper limit. Could reflect mild infection, chronic inflammation (common in diabetes/metabolic syndrome), or stress response.
- Action needed: Serum iron, TIBC, ferritin, and peripheral smear to confirm iron deficiency anemia and its cause.
OVERALL CLINICAL PICTURE
This 52-year-old male presents with a classic metabolic syndrome profile:
| Component | Finding |
|---|---|
| Diabetes | ✅ Present - poorly controlled |
| Dyslipidemia | ✅ Present - low HDL, high TG, high LDL |
| Fatty Liver (likely) | ✅ Probable - elevated SGPT/SGOT pattern |
| Anemia | ✅ Likely iron deficiency |
| Platelet activation | ✅ Elevated MPV/PDW - cardiovascular risk |
Cardiovascular risk is significantly elevated in this patient given the combination of: age (52, male), diabetes (HbA1c 8%), dyslipidemia (low HDL + high TG + high LDL), elevated platelet activity, and likely NAFLD.
RECOMMENDED NEXT STEPS
- Consult a physician - ideally an internist or diabetologist, urgently
- Glycemic optimization - HbA1c target < 7% (consider adding/adjusting antidiabetics, possibly metformin + SGLT2i which also helps the liver and heart)
- Statin therapy - given diabetic status + LDL > 100
- Fibrate or omega-3 - for triglycerides > 150 + low HDL
- Abdominal ultrasound - to assess fatty liver
- Iron studies (serum ferritin, TIBC) - to confirm and treat iron deficiency anemia
- Dietary changes - low glycemic index diet, reduce saturated fats, increase physical activity
- Cardiac risk assessment - consider ECG, stress test given the multiple risk factors
Disclaimer: This interpretation is for educational purposes. All findings must be correlated with clinical symptoms and evaluated by a qualified physician before any treatment decisions are made.
This is a shared conversation. Sign in to Orris to start your own chat.